PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
NYU CTSI Research Pharmacy (Drug Shipment Address), New York, New York, United States
Clinical and Translational Science Institute (CTSI), New York, New York, United States
NYU School of Medicine, New York, New York, United States
Connecticut Mental Health Center, New Haven, Connecticut, United States
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Arthritis & Rheumatic Care Center, Miami, Florida, United States
CEDRA Clinical Research, LLC, San Antonio, Texas, United States
Centrum for klinisk provning, Goteborg, Sweden
Pfizer Investigational Site, Singapore, Singapore
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.